Cell Source, Inc. (CLCS) has an overall financial health rating of C with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-12-30.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-08 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-12-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
